Breaking News
March 23, 2019 - Lung cancer survivor recounts her lifetime struggles
March 23, 2019 - Radial and femoral approach for PCI achieve similar results in terms of survival
March 23, 2019 - Study sheds light on the optimal timing of coronary angiography in NSTEMI patients
March 23, 2019 - Excess hormones could cause a condition that can lead to blindness in women, study finds
March 23, 2019 - Dramatic shifts in first-time opioid prescriptions bring hope, concern
March 23, 2019 - Antidepressant drugs may not work when neurons are out of shape
March 23, 2019 - TTUHSC El Paso to establish endowed chair in neurology through a major grant
March 23, 2019 - New device approved by FDA for treating patients with moderate-to-severe heart failure
March 23, 2019 - People with peripheral artery disease have lower Omega-3 Index, shows research
March 23, 2019 - Trigger warnings have minimal impact on how people respond to content, shows research
March 23, 2019 - Gilead Announces Data From Two Studies Supporting Further Development of GS-6207, a Novel, Investigational HIV-1 Capsid Inhibitor as a Component of Future Long-Acting HIV Therapies
March 23, 2019 - Selfish genetic elements amplify inflammation and age-related diseases
March 23, 2019 - Study provides new understanding of how the brain recovers from damage caused by stroke
March 23, 2019 - CRISPR/Cas libraries could revolutionize drug discovery
March 23, 2019 - Allergic reaction during pregnancy may alter sexual-development in offspring’s brain
March 23, 2019 - Seeing through a robot’s eyes helps those with profound motor impairments
March 23, 2019 - Recent research shows that ease of breastfeeding after C-section differs culturally
March 23, 2019 - Newly discovered parameters offer more control over efficient release of drugs
March 23, 2019 - ‘De-tabooing’ of abortion- Women would like more support from health care community
March 23, 2019 - Anti-TB drugs can increase susceptibility to Mtb reinfection
March 23, 2019 - New survey indicates need of attention to neglected tropical diseases
March 23, 2019 - Innovative in vitro method to develop easy-to-swallow medicine for children and older people
March 23, 2019 - Sugary drinks could raise risk of early deaths finds study
March 23, 2019 - Lian wins ENGINE grant for stem-cell-based therapy to treat Type 1 diabetes
March 23, 2019 - Overall, Physicians Are Happy and Enjoy Their Lives
March 23, 2019 - Researchers discover how blood vessels protect the brain during inflammation
March 23, 2019 - CDC study shows modest improvement in optimal hospital breastfeeding policy
March 23, 2019 - Family-based prevention program to reduce alcohol use among older teens
March 23, 2019 - Remote monitoring of implanted defibrillators in heart failure patients prevents hospitalizations
March 23, 2019 - Appropriate doffing of personal protective equipment may reduce healthcare worker contamination
March 23, 2019 - Window screens can suppress mosquito populations, reduce malaria in Tanzania
March 23, 2019 - Researchers discover new biomarker for postoperative liver dysfunction
March 23, 2019 - Pregnancy history may be linked to cognitive function in older women, finds study
March 23, 2019 - Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack
March 23, 2019 - FDA Approves First Drug for Postpartum Depression, Zulresso (brexanolone)
March 23, 2019 - New guidelines outline new treatment management for psoriasis
March 23, 2019 - Thermally abused cooking oil may promote progression of breast cancer
March 23, 2019 - High-fructose corn syrup fuels growth of colon tumors in mice
March 23, 2019 - Partnership aims at establishing best practices to promote diversity in clinical trials
March 23, 2019 - New study examines presence of microbes in tap water from residences, office buildings
March 23, 2019 - Early life trauma may affect brain structure, contribute to major depressive disorder
March 23, 2019 - NIH starts clinical trial of drug to treat cravings associated with opioid use disorder
March 23, 2019 - Cervix bacteria, immune factors could be a warning signal of premature birth, reports new research
March 23, 2019 - Worst-ever emergency care performance figures underscore the need to focus on staffing
March 23, 2019 - The Current issue of “The view from here” is concerned with Cancer
March 23, 2019 - Mouse model validates how ‘good’ and ‘bad’ bacteria affect acne
March 23, 2019 - Individual amygdala neurons respond to touch, imagery and sounds
March 23, 2019 - Combination of two topical creams can prevent cancer
March 23, 2019 - Study suggests depression screening when assessing African-Americans for schizophrenia
March 23, 2019 - New electronic support system for choosing drug treatment based on patient’s genotype
March 23, 2019 - First-of-its-kind study provides pregnancy statistics of imprisoned U.S. women
March 23, 2019 - Marinus Pharmaceuticals Initiates Phase 3 Study in Children with PCDH19-Related Epilepsy
March 23, 2019 - Laparoscopy: MedlinePlus Lab Test Information
March 23, 2019 - Shellfish allergies: can they be treated?
March 23, 2019 - Toilet seat heart monitoring system
March 23, 2019 - Researchers identify way to improve common treatment for PTSD
March 23, 2019 - High potency cannabis use linked to psychosis finds study
March 23, 2019 - Evoke Pharma Submits Response to FDA Review Letter for Gimoti NDA
March 23, 2019 - Tracking HIV’s ever-evolving genome in effort to prioritize public health resources
March 23, 2019 - Scientists grow most sophisticated brain organoid to date
March 23, 2019 - ADHD drug raising risk of psychosis
March 22, 2019 - FDA approves brexanolone, first drug developed to treat postpartum depression
March 22, 2019 - Gruesome cat and dog experiments by the USDA exposed
March 22, 2019 - Ball pits used in children’s physical therapy may contribute to germ transmission
March 22, 2019 - Long-term use of inexpensive weight-loss drug may be safe and effective
March 22, 2019 - FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
March 22, 2019 - Anti-Müllerian Hormone Test: MedlinePlus Lab Test Information
March 22, 2019 - Finding the right exercise, diet aids for HIV patients
March 22, 2019 - Health Plans For State Employees Use Medicare’s Hammer On Hospital Bills
March 22, 2019 - Researchers develop new tool for imaging large groups of neurons in living animals
March 22, 2019 - Certain bacteria and immune factors in vagina may cause or protect against preterm birth
March 22, 2019 - Research identifies guidelines for prioritizing hepatitis C treatment in U.S. prisons
March 22, 2019 - Novel breath test could pave new way to non-invasively measure gut health
March 22, 2019 - Pharmaceutical and personal care products may result in new contaminants in waterways
March 22, 2019 - New model could revolutionize the way researchers investigate spread of pathogens
March 22, 2019 - MSU professor receives NSF CAREER grant for biosensor diagnostics
March 22, 2019 - High-fat, high-sugar diet in mouse mothers causes problems in the hearts of offspring
March 22, 2019 - ACC: Catheter Ablation Does Not Cut Mortality, Stroke in A-Fib
March 22, 2019 - Wiedemann-Rautenstrauch syndrome – Genetics Home Reference
March 22, 2019 - Health insurance is not assurance of healthcare
Potential drug targets for ALS revealed in study using CRISPR

Potential drug targets for ALS revealed in study using CRISPR

image_pdfDownload PDFimage_print
An MRI with increased signal in the posterior part of the internal capsule which can be tracked to the motor cortex consistent with the diagnosis of ALS. Credit: Frank Gaillard/Wikipedia

In a new application of gene-editing technology, researchers at the Stanford University School of Medicine have gleaned insights into the genetic underpinnings of amyotrophic lateral sclerosis, a neurodegenerative disease that’s notoriously tricky to parse.

The team’s findings are a step toward demystifying how the disease progresses and could even help lay the groundwork for new therapeutic targets.

ALS, also known as Lou Gehrig’s disease, erodes muscle function and impairs the brain’s ability to communicate with the body, making simple voluntary muscle movements—such as brushing your teeth, talking or even breathing—exceedingly difficult and, eventually, impossible. ALS falls into a category of neurodegenerative diseases that all share a common “signature”—abnormal protein clumps that build up in the brain.

In ALS, these protein clumps, or aggregates, are thought to be fatally toxic to neurons, ultimately leading to the devastating physical symptoms of the disease. But the process of the cells’ demise is still largely a black box.

“These toxic protein aggregates are what’s likely driving the pathology in the disease, but no one really knows how they cause neuronal cell death. That’s really what we wanted to probe in this study,” said Aaron Gitler, PhD, professor of genetics. He shares senior authorship with Michael Bassik, PhD, assistant professor of genetics.

Gitler’s and Bassik’s labs used CRISPR-Cas9 gene-editing technology to sort through the entire human genome and pick out the genes that helped neurons shore up defenses against the toxic protein. Not only did some genes give the researchers a deeper mechanistic understanding of the disease itself; a handful seem to hold potential as drug targets, too.

A paper describing the research will be published online March 5 in Nature Genetics. Graduate students Nicholas Kramer and Michael Haney share lead authorship.

A simple but deadly protein

The discovery that mutations in the C9orf72 gene is a relatively common cause of ALS has helped ignite efforts to understand how ALS works at the molecular level. In ALS, the mutated C9orf72 gene contains a huge segment of DNA that repeats itself and, when that part of the gene is erroneously turned into various rogue proteins, they gum up neuronal function and lead to cell death.

“In a healthy person, you might see 10 to 20 of these DNA repeats,” Haney said. “But in ALS, they expand to hundreds or even thousands of repeated segments, and that’s the template for the production of these toxic proteins.”

Gitler and Bassik set out to answer two basic questions: How do the toxic proteins snuff out otherwise healthy neurons? And are there other genes that inherently protect against—or conversely, exacerbate—the effects of the toxic proteins in the brain?

Rather than separately interrogate every gene in the human repository, the researchers used a tactic called genomewide screening, which harnesses CRISPR-Cas9 to alter the function of every single human gene simultaneously. In this case, they used the technology to produce “gene knockouts,” targeting genes with a kind of molecular scissors that makes precise cuts, leaving them unable to carry out normal function.

The gene knockouts, Kramer explained, help the researchers spot genes that either enhance toxicity or prevent it: If you identify a gene and knock it out, and the ALS protein repeats are no longer toxic, then you know that the absence of that gene actually protects the neuron against degeneration. And perhaps more importantly, it may be a potential drug target.

Tmx2: A sentinel of cell death

After systematically knocking out every gene in the human genome and measuring the toxicity of the ALS proteins in cells, the researchers found that about 200 genes, when knocked out, either helped to protect the cell from the toxic proteins or made it more vulnerable to them. To zero in on a smaller set of genes, Haney and Kramer followed up with two subsequent knockout screens in primary mouse neurons.

They found a handful of knockouts that were particularly potent protectors. One, for example, helped block off critical entrances through which the toxic ALS proteins infiltrate the cell and corrupt it. But there was another knockout in particular that caught the group’s attention for its mysterious ability to ward off neural death. The gene normally codes for a protein called Tmx2, which is found in a part of the cell called the endoplasmic reticulum. But when depleted in mouse neurons in a dish, the cells survived nearly 100 percent of the time—quite a jump, considering that the survival rate for normal neurons was 10 percent.

“We could imagine that Tmx2 might make good drug target candidate,” Haney said. “If you have a small molecule that could somehow impede the function of Tmx2, there might be a therapeutic window there.”

Right now, Tmx2’s role in the endoplasmic reticulum isn’t completely clear. But it’s thought to be involved in the response to various environmental stressors, particularly those that trigger cell death. According to the study’s findings, it may be a modulator of other genes that set off the cell-death process.

“We’re still in early phases, but I think figuring out exactly what Tmx2 normally does in a cell is a good place to start—that would hint at what functions are disturbed when these toxic species kill the cell, and it could point to what pathways we should look into,” Kramer said.

More broadly, CRISPR screens like the one in this study have been used to investigate a range of disease pathways. But the team said this is the first time, to their knowledge, that a genomewide human CRISPR knockout screen has been used to discover clues about a neurodegenerative disorder. Gitler and Bassik are currently teaming up to use this same approach to understand additional causes of ALS and even other neurological diseases—Huntington’s, Parkinson’s and Alzheimer’s—that involve toxic proteins. “I think it’s a really exciting application for CRISPR screens, and this is just the beginning,” Bassik said.


Explore further:
Scientists move closer to treatment for Huntington’s disease

More information:
CRISPR–Cas9 screens in human cells and primary neurons identify modifiers of C9orf72 dipeptide-repeat-protein toxicity, Nature Genetics (2018). nature.com/articles/doi:10.1038/s41588-018-0070-7

Journal reference:
Nature Genetics

Provided by:
Stanford University Medical Center

Tagged with:

About author

Related Articles